For her most recent efforts, Bruckner-Lea, a senior technical advisor at PNNL, received the Secretary’s Appreciation Award from the U.S. Secretary of Energy Jennifer Granholm in July.

The Quick Building Assessment Tool is a simplified building energy analysis tool designed specifically for users with no experience in buildings.

PNNL has named Biomedical Scientist Tom Metz, an expert on metabolomics and multi-omics within the Biological Sciences Division, a 2023 Laboratory Fellow.

Small teams in the Biological Sciences Division at PNNL and at EMSL—the Environmental and Molecular Sciences Laboratory, an Office of Science user facility at PNNL—are pros at preparation.

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

Joshua Adkins and Jamie Lo will lead PMedIC, Pacific Northwest National Laboratory and Oregon Health & Science University’s joint research institute.

PNNL scientists are creating new ways to learn more about the vast sea of chemicals that haven't been identified—yet.

PNNL receives a 2023 Federal Laboratory Consortium Far West Regional Award for a technological innovation that could help make the U.S. a producer of critical minerals used in electronics and energy production.

Metabolomics analysis revealed differences in metabolome profiles for two distinct modes of fungal wood decay.

Methods review suggests ways to use artificial intelligence and machine learning to handle missing data when integrating two or more omics approaches.

PNNL chemist Christopher Anderton recently named president-elect of the Imaging Mass Spectrometry Society (IMSS). In this new position, he will help lead the merge of IMSS with a European-based society, currently underway.

PNNL’s Katie Arkema was selected to be on NASEM committee focused on public health and conservation.

Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.

Exploring why some brains are more resilient to the impact of Alzheimer’s disease could lead to improved diagnoses, treatment and prevention.

Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

Staff at PNNL recently completed a report highlighting commercial products enabled through projects funded by the Department of Energy’s Building Technologies Office.

Findings show method to better prepare human lung tissue for study; it represents the latest mass spectrometry-based omics advances.

The Simple Building Calculator, developed at PNNL, meets a need for a quick, interactive, and economic method to evaluate energy use—and potential savings from efficiency measures—in simple commercial buildings.

For a second year in a row, doctoral intern Jack Watson was awarded the Student Merit Award by the Society for Risk Analysis and the Resilience Analysis Specialty group.